Literature DB >> 33512165

Prediction of Oral Pharmacokinetics Using a Combination of In Silico Descriptors and In Vitro ADME Properties.

Yohei Kosugi1, Natalie Hosea1.   

Abstract

Accurate prediction of oral pharmacokinetics remains challenging. This study investigated quantitative approaches for the prediction of the area under the plasma concentration-time curve after oral administration (AUCp,oral) to rats using the in vitro-in vivo extrapolation (IVIVE), in silico model using machine learning approaches and the combination of the in silico model and in vitro data. A set of 595 structurally diverse compounds with determined AUCp,oral at 1 mg/kg, in vitro intrinsic clearance (CLint), an unbound fraction in plasma (fu,p) in rats, and kinetic solubility at pH 6.8 was used for this assessment. Prediction models developed by two different types of machine learning techniques (i.e., random forest regression and Gaussian processes) were evaluated using three validation methods implementing the time and cluster-split training and test set and fivefold cross-validation. The developed machine learning models have a square of correlation coefficient (R2) in the range of 0.381-0.685 with 33-45% of the compounds being predicted within 2-fold of the observed AUCp,oral value. The predictivity was improved by incorporating CLint, fu,p, and solubility as explanatory variables with R2 = 0.554-0.743. In cases where extraction by the liver is the main elimination pathway and intestinal extraction is negligible, AUCp,oral can be expressed by dose, CLint, and fu,p based on a well-stirred model. By using this conventional IVIVE approach, only 1.7-5.0% of compounds were predicted within the 2-fold error with R2 = 0.354-0.487. Two empirical scaling factors (ESFs) determined by linear regression analysis and machine learning approaches improved the predictivity of AUCp,oral with 33-44% predicted within twofold variability. The IVIVE using ESF predicted by random forest regression showed better predictivity of AUCp,oral with R2 = 0.471-0.618, while it still showed lower predictivity than machine learning approaches applied directly to AUCp,oral prediction. This study demonstrated that the combination of in silico and in vitro parameters is useful to improve the predictivity of the machine learning model for rat AUCp,oral and supports consideration for predicting AUCp,oral for human and other non-clinical species in a similar manner.

Entities:  

Keywords:  bottom-up approach; in silico; in vitro−in vivo extrapolation (IVIVE); machine learning; oral clearance prediction; plasma protein binding; quantitative structure−activity relationship (QSAR); well-stirred model

Year:  2021        PMID: 33512165     DOI: 10.1021/acs.molpharmaceut.0c01009

Source DB:  PubMed          Journal:  Mol Pharm        ISSN: 1543-8384            Impact factor:   4.939


  4 in total

1.  Designing QSARs for Parameters of High-Throughput Toxicokinetic Models Using Open-Source Descriptors.

Authors:  Daniel E Dawson; Brandall L Ingle; Katherine A Phillips; John W Nichols; John F Wambaugh; Rogelio Tornero-Velez
Journal:  Environ Sci Technol       Date:  2021-04-15       Impact factor: 9.028

2.  Direct Comparison of the Prediction of the Unbound Brain-to-Plasma Partitioning Utilizing Machine Learning Approach and Mechanistic Neuropharmacokinetic Model.

Authors:  Yohei Kosugi; Kunihiko Mizuno; Cipriano Santos; Sho Sato; Natalie Hosea; Michael Zientek
Journal:  AAPS J       Date:  2021-05-18       Impact factor: 4.009

3.  Studying and mitigating the effects of data drifts on ML model performance at the example of chemical toxicity data.

Authors:  Andrea Morger; Marina Garcia de Lomana; Ulf Norinder; Fredrik Svensson; Johannes Kirchmair; Miriam Mathea; Andrea Volkamer
Journal:  Sci Rep       Date:  2022-05-04       Impact factor: 4.996

4.  Investigation of potential descriptors of chemical compounds on prevention of nephrotoxicity via QSAR approach.

Authors:  Hung-Jin Huang; Yu-Hsuan Lee; Chu-Lin Chou; Cai-Mei Zheng; Hui-Wen Chiu
Journal:  Comput Struct Biotechnol J       Date:  2022-04-15       Impact factor: 6.155

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.